U.S CDC investigates harmful reactions to counterfeit Botox injections
America
By
Xinhua
| Apr 16, 2024
The U.S Centers for Disease Control and Prevention (CDC) is investigating reports of harmful reactions among people who received injections of counterfeit or mishandled botulinum toxin, known as "Botox," the agency said on Monday.
As of Monday, the CDC has received reports of 19 people in nine states who experienced harmful reactions after receiving counterfeit Botox injections or injections administered by unlicensed or untrained individuals and (or) in non-healthcare settings, such as homes or spas.
Nine people have been hospitalized and four were treated with botulism antitoxin because symptoms were consistent with the possible spread of toxin, according to the CDC. No deaths have been reported.
Many of the products being investigated are counterfeit or were administered in non-healthcare settings, such as homes and spas, or by an unlicensed or untrained individual, according to the CDC.
The CDC is working with several state and local health departments. Moreover, the U.S. Food and Drug Administration (FDA) has intervened in the investigation.
READ MORE
KQ suspends flights to Kinshasa over detention of staff
Six-month loan moratorium will ease financial strain on businesses affected by floods
Is government on 'fuliza' mode?
Expert: The shilling has regained value, but don't expect it to last
EAC Central Bank Governors meet in Juba as single currency race debate heats up
Ruto to push for global finance reforms at World Bank meeting
Unearthing the artifacts of WWII: A journey through Matuu and beyond
Roam, County Bus Service partner to deploy 200 electric buses
Budget cuts loom for Parliament thanks to Sh9.6b Bunge Towers